Arai, S., Jonas, O., Whitman, M. A., Corey, E., Balk, S. P., & Chen, S. (2018). Tyrosine Kinase Inhibitors Increase MCL1 Degradation and in Combination with BCLXL/BCL2 Inhibitors Drive Prostate Cancer Apoptosis. Clin Cancer Res.
Citação norma ChicagoArai, Seiji, Oliver Jonas, Matthew A. Whitman, Eva Corey, Steven P. Balk, and Sen Chen. "Tyrosine Kinase Inhibitors Increase MCL1 Degradation and in Combination With BCLXL/BCL2 Inhibitors Drive Prostate Cancer Apoptosis." Clin Cancer Res 2018.
Citação norma MLAArai, Seiji, et al. "Tyrosine Kinase Inhibitors Increase MCL1 Degradation and in Combination With BCLXL/BCL2 Inhibitors Drive Prostate Cancer Apoptosis." Clin Cancer Res 2018.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.